STUDY SUGGESTS DELAY BETWEEN DIAGNOSIS AND TREATMENT OF PROSTATE CANCER MAY NOT AFFECT OUTCOME

In a study done at Fox Chase Cancer Center in Philadelphia, Pennsylvania, researchers have found that a delay in treating prostate cancer may not significantly affect the ultimate outcome for the patient.

Analysis of the records of 1,322 men diagnosed and treated for prostate cancer showed that there was little statistical difference in outcome between those in four different “time to treatment” groups. Whether treatment was commenced less than 3 months, 3-6 months, 6-9 months, or 9-12 months after diagnosis made no appreciable clinical or biochemical difference in outcome even in high-risk patients.

The results of the study are seen as a way to decrease the enormous stress suffered by patients between the time of biopsy and diagnosis and certainly in the time between diagnosis and treatment. It also allows for more leeway for making an informed decision as to treatment.

This entry was posted in Legal News. Bookmark the permalink.


© 2005-2016 Parker Waichman LLP ®. All Rights Reserved.